DataMeds AI unit Corexa Pharmacy tops $1 million in September revenue
MEDS•Corexa Pharmacy posted preliminary September 2026 revenue above $1 million, up more than 66% from July 2026.
MEDS•MEDS•MEDS•Corexa Pharmacy posted preliminary September 2026 revenue above $1 million, up more than 66% from July 2026.
Corexa Pharmacy, a unit of DataMeds AI’s wholly owned Corexa Health subsidiary, posted preliminary September 2026 revenue above $1 million. Revenue rose more than 66% from July, following completion of the pharmacy’s rebrand early in the third quarter.
Management flagged prescription volume and adjunct product sales, with an emphasis on GLP-1 therapies and Long COVID patients. Corexa Pharmacy is being upgraded as a flagship site for the Health Lives Here initiative, which aims to scale across Corexa Health’s 6,500-pharmacy network.
